160514-13-6 (洛沙坦杂质B 标准品,2'-(1H-Tetrazol-5-yl)biphenyl-4-ylmethanol)

2-[(1H-四唑-5-基)联苯-4-基]甲醇;厄贝沙坦杂质C;氯沙坦杂质B;洛沙坦杂质B 标准品;2'-(2H-四唑-5-基)-[1,1'-联苯]-4-甲醇;缬沙坦杂质26;氯沙坦EP杂质B;氯沙坦钾EP杂质B;

2'-[(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol;2´-[(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol;[1,1'-Biphenyl]-4-methanol, 2'-(2H-tetrazol-5-yl)-;2?-[(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol;[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methanol;Irbesartan Impurity 7;Valsartan Impurity 26;Losartan EP IMpurity B;2'-(1H-Tetrazol-5-yl)-;2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-methanol;Losartan EP IMpurity B (Losartan HydroxyIMpurity );(2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol;LOSARTAN POTASSIUM IMPURITY B [EP IMPURITY];A899334;(2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol;UNII-14NFA600H4;DTXSID20166899;AKOS027335464;MFCD18379631;14NFA600H4;[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]-methanol;F50075;Losartan Potassium Imp. B (EP); Losartan Imp. B (EP); [2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol; Losartan Potassium Impurity B; Losartan Impurity B;160514-13-6;ZRQJTHPAIULYJV-UHFFFAOYSA-N;5-(4'-Hydroxymethylbiphenyl-2-yl)-1H-tetrazole;[2'-(2H-1,2,3,4-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL]METHANOL;Losartan potassium impurity B [EP];(2'-(1H-Tetrazol-5-yl)biphenyl-4-yl)methanol;SCHEMBL1773521;(1,1'-Biphenyl)-4-methanol, 2'-(2H-tetrazol-5-yl)-;Q27251639;Losartan EP Impurity B (Losartan Hydroxy Impurity/ Irbesartan Hydroxy Impurity/ Candesartan Hydroxy Impurity);C90688;[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol;

MFCD18379631

ZRQJTHPAIULYJV-UHFFFAOYSA-N

1S/C14H12N4O/c19-9-10-5-7-11(8-6-10)12-3-1-2-4-13(12)14-15-17-18-16-14/h1-8,19H,9H2,(H,15,16,17,18)

OCC1C=CC(=CC=1)C1=CC=CC=C1C1N=NNN=1